NCT01272947View on ClinicalTrials.gov

Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Applied Four Times Daily in Subjects With Acute Blunt Trauma Injuries

PHASE3CompletedINTERVENTIONAL
Enrollment

204

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
Acute Blunt Soft Tissue Injuries/Contusions
Interventions
DRUG

Diclofenac sodium

Topical gel 1%- 4 times daily

OTHER

Placebo

Topical gel - 4 times daily

Trial Locations (6)

Unknown

NCH investigative site, Brühl

NCH investigative site, Butzbach

NCH investigative site, Cologne

NCH investigative site, Essen

NCH investigative site, Gilching

NCH investigative site, Munich

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT01272947 - Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Applied Four Times Daily in Subjects With Acute Blunt Trauma Injuries | Biotech Hunter | Biotech Hunter